Hypofractionation with simultaneous integrated boost for early breast cancer: Results of the German multicenter phase II trial (ARO-2010-01)

Strahlentherapie und Onkologie

Volumn 190, Issue 7, 2014, Pages 646-653

  Dellas, Kathrin ^a,b   Vonthein, Reinhard ^b   Zimmer, Jörg ^c   Dinges, Stefan ^d   Boicev, Alexander D ^e   Andreas, Peter ^f   Fischer, Dorothea ^b   Winkler, Cornelia ^g   Ziegler, Andreas ^b   Dunst, Jürgen ^a,b,h  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c Private Practices   (Germany)

^d Hospital Lüneburg   (Germany)

^e Department of Radiooncology Klinikum Zwickau   (Germany)

^f Krankenhaus Buchholz und Winsen GmbH   (Germany)

^g TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^h UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Breast cancer; Feasibility; Hypofractionation; Simultaneous integrated boost; Toxicity

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; FEMALE; GERMANY; HEART; HOT FLUSH; HUMAN; HUMAN TISSUE; LUNG; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DOSE FRACTIONATION; EARLY DIAGNOSIS; FEASIBILITY STUDIES; FEMALE; GERMANY; HUMANS; MIDDLE AGED; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 84903380308     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-014-0658-5     Document Type: Article

References (16)

1. Clarke M, Collins R, Darby S et al, Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087-2106
2. Darby S, McGale P, Correa C et al (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378:1707-1716
3. Whelan TJ, Julian J, Wright J et al (2000) Does locoregional RT improve survival in breast cancer? A meta-analysis. J Clin Oncol 18:1220-1229 (Pubitemid 30159839)
4. Bartelink H, Horiot JC, Poortmans P et al (2007) Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 22:3259-3326
5. Livi L, Borghesi S, Saieva C et al (2009) Benefit of radiation boost after whole-breast radiotherapy. Int J Radiat Oncol Biol Phys 75:1029-1034
6. Azria D, Auvray H, Barillot I et al (2008) Ductal carcinoma in situ: role of the boost. Cancer Radiother 12:571-576
7. Whelan TJ, Pignol JP, Levine MN et al (2010) Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 362:513-520
8. START Trialists' Group, Bentzen SM, Agrawal RK, Aird EG et al (2008) The UK Standardization of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 9:331-341
9. START Trialists' Group, Bentzen SM, Agrawal RK, Aird EG et al (2008) The UK Standardization of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 371:1098-1107
10. Owen JR, Ashton A, Bliss JM et al (2006) Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomized trial. Lancet Oncol 7:467-471 (Pubitemid 43779171)
11. Sedlmayer F, Sautter-Bihl ML, Budach W et al (2013) Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO). Is the simultaneously integrated boost (SIB) technique for early breast cancer ready to be adopted for routine adjuvant radiotherapy? Statement of the German and the Austrian Societies of Radiooncology (DEGRO/ÖGRO). Strahlenther Onkol 189:193-196
12. Sedlmayer F, Sautter-Bihl ML, Budach W et al (2013) Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO). DEGRO practical guidelines: radiotherapy of breast cancer I. Radiotherapy following breast conserving therapy for invasive breast cancer. Strahlenther Onkol 189:825-833
13. Chadha M, Vongtama D, Friedmann P et al (2012) Comparative acute toxicity from whole breast irradiation using 3-week accelerated schedule with concomitant boost and the 6.5-week conventional schedule with sequential boost for early-stage breast cancer. Clin Breast Cancer 12:57-62
14. Van Parijs HM, Vinh-Hung V et al (2012) Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial. Radiat Oncol 7:80
15. Scorsetti M, Alongi F, Fogliata A et al (2012) Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments. Radiat Oncol 28:145
16. Darby SC, Ewertz M, McGale P et al (2012) Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 368:987-998